retatrutide benefits research Substack Series 3 of 6: – The Next Frontier in Longevity and Metabolic Health Retatrutide Weight Loss Treatment Explained

Orforglipron, the easier-to-use alternative to injectable weight-loss and diabetes medications, is a promising new tool with improved convenience for providers and patients

Clinical scenarios warranting consideration of GLP-1 therapy include: Type 2 diabetes management : Per ADA 2024 Standards of Care, GLP-1 RAs may be considered as initial therapy in patients with established atherosclerotic cardiovascular disease (ASCVD), high ASCVD risk, chronic kidney disease (CKD), or heart failure, or as add-on therapy when glycemic targets aren't met Established cardiovascular disease : Several GLP-1 receptor agonists have demonstrated cardiovascular risk reduction in patients with type 2 diabetes and established ASCVD Chronic kidney disease : While SGLT2 inhibitors are generally prioritized for CKD with type 2 diabetes when eGFR allows, GLP-1 RAs may provide complementary benefits Obesity with complications : When lifestyle interventions produce insufficient weight loss in patients with obesity-related comorbidities Important safety considerations include: Contraindications : Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

As a supplement, acetyl-L-carnitine is usually considered safe when taken as directed

Table 2: Comparative analysis of Liposomal and Non-liposomal Vitamin C These studies conclusively show that liposomal Vitamin C offers enhanced bioavailability, making it far more effective than traditional forms in terms of absorption and therapeutic impact

Our aesthetic med spa offers treatments to enhance natural beauty, including microneedling, chemical peels, and non-invasive body contouring

Circulation 146(24):18821894 Mary P, Curtis R (2010) Weighing risks and benefits of liraglutide the FDAs review of a new antidiabetic therapy